LEAP Participant Follow-up Study Publication

The LEAP Trio Participant Follow-up manuscript was published today in the NEJM Evidence.  The LEAP Trial, published in 2015, demonstrated that early introduction of peanut prevented development of peanut allergy at 5 years of age. The LEAP Trio study, which follows the original LEAP Trial participants out to adolescence, shows that early peanut consumption, starting in infancy and continuing to age five years, provides lasting tolerance to peanut into adolescence irrespective of subsequent peanut consumption. This study demonstrates for the first time that long-term prevention and tolerance can be achieved in food allergy.

Read the publication in NEJM Evidence